{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-005292","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.970430+00:00","generated_at":"2026-06-07T01:24:21.615160+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Catalyst Pharmaceuticals closes $150M public offering of 10M shares at $15; net proceeds ~$140.1M","bullets":["Sold 10,000,000 shares of common stock at $15.00 per share in an underwritten public offering.","Net proceeds after underwriting discounts and estimated expenses were approximately $140.1 million.","Underwriters granted a 30-day option to purchase up to an additional 1,500,000 shares.","Proceeds to be used for potential acquisition of new product candidates and general corporate purposes.","Bookrunners: BofA Securities, Citigroup, Piper Sandler, Cantor, Truist Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-005292","json":"https://secwatch.observer/filing/0001193125-24-005292.json","markdown":"https://secwatch.observer/filing/0001193125-24-005292.md","text":"https://secwatch.observer/filing/0001193125-24-005292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524005292/0001193125-24-005292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524005292/d702064d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:24:21.615160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}